Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis
- PMID: 22852842
- PMCID: PMC3438803
- DOI: 10.1089/gtmb.2012.0050
Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis
Abstract
The association between hepatocellular carcinoma (HCC) and the 61A>G polymorphism in the epidermal growth factor (EGF) gene has been analyzed in several studies, but results have been inconsistent. The aim of this study was to integrate previous findings and explore whether this polymorphism is associated with susceptibility to HCC. A meta-analysis was performed by searching PubMed, Web of Science, and Cochrane Library databases. Data were extracted using predefined form and pooled odds ratios (OR) with 95% confidence intervals (CI) and were calculated to evaluate the strength of this association. Five studies involving 690 cases, 514 healthy controls, and 1419 controls with cancer-free liver diseases were identified. On the basis of healthy controls, the significant main effects on HCC risk were observed in a heterozygote comparison (OR=1.76, 95% CI 1.07-2.90, p=0.02) and a dominant genetic model (OR=1.65, 95% CI 1.03-2.66, p=0.04). On the basis of the controls with cancer-free liver diseases, a significantly increased risk of HCC was found in all the genetic models. Subgroup analyses stratified by ethnicity and etiology of HCC also showed positive associations. The EGF 61G allele is a risk factor for developing HCC without the influence of ethnic and etiological diversity.
Figures
Similar articles
-
Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.BMC Cancer. 2015 Apr 25;15:314. doi: 10.1186/s12885-015-1318-6. BMC Cancer. 2015. PMID: 25927412 Free PMC article.
-
Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.PLoS One. 2012;7(3):e32159. doi: 10.1371/journal.pone.0032159. Epub 2012 Mar 5. PLoS One. 2012. PMID: 22403631 Free PMC article.
-
Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.Asian Pac J Cancer Prev. 2015;16(7):3009-14. doi: 10.7314/apjcp.2015.16.7.3009. Asian Pac J Cancer Prev. 2015. PMID: 25854398
-
Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.Gene. 2019 Feb 15;685:143-148. doi: 10.1016/j.gene.2018.11.012. Epub 2018 Nov 4. Gene. 2019. PMID: 30403964 Review.
-
EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.Gene. 2013 Apr 25;519(1):26-33. doi: 10.1016/j.gene.2013.01.057. Epub 2013 Feb 9. Gene. 2013. PMID: 23403233 Review.
Cited by
-
Association of the epidermal growth factor gene +61A>G polymorphism with hepatocellular carcinoma in an Iranian population.Gastroenterol Hepatol Bed Bench. 2017 Fall;10(4):284-288. Gastroenterol Hepatol Bed Bench. 2017. PMID: 29379593 Free PMC article.
-
Epidermal growth factor, from gene organization to bedside.Semin Cell Dev Biol. 2014 Apr;28:2-11. doi: 10.1016/j.semcdb.2014.01.011. Epub 2014 Feb 7. Semin Cell Dev Biol. 2014. PMID: 24513230 Free PMC article. Review.
-
Host genetics predict clinical deterioration in HCV-related cirrhosis.PLoS One. 2014 Dec 12;9(12):e114747. doi: 10.1371/journal.pone.0114747. eCollection 2014. PLoS One. 2014. PMID: 25504078 Free PMC article.
-
EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.Int J Clin Oncol. 2021 Nov;26(11):2053-2064. doi: 10.1007/s10147-021-01994-w. Epub 2021 Jul 21. Int J Clin Oncol. 2021. PMID: 34291370
-
A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients.Onco Targets Ther. 2013 Dec 13;6:1805-12. doi: 10.2147/OTT.S53625. eCollection 2013. Onco Targets Ther. 2013. PMID: 24363559 Free PMC article.
References
-
- Berasain C. Perugorria MJ. Latasa MU, et al. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) 2009;234:713–725. - PubMed
-
- Chen K. Wei YG. Yang HT, et al. Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. Genet Test Mol Biomarkers. 2011;15:251–255. - PubMed
-
- Goto Y. Ando T. Goto H, et al. No association between EGF gene polymorphism and gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:2454–2456. - PubMed
-
- Grunwald V. Hidalgo M. Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Natl Cancer Inst. 2003;95:851–867. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical